Simulation of tumor microvasculature and microenvironment response to anti-angiogenic treatment by angiostatin and endostatin

Applied Mathematics and Mechanics (English Edition)

Volumn 32, Issue 4, 2011, Pages 437-448

  Wu, Jie ^a   Ding, Zu Rong ^a   Cai, Yan ^b   Xu, Shi Xiong ^b   Zhao, Gai Ping ^c   Long, Quan ^d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^d BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

anti angiogenesis; microenvironment normalization; numerical simulation; solid tumor

Indexed keywords

ANGIOGENESIS; ANGIOSTATIN; BLOOD PERFUSION; ENDOSTATINS; HAEMODYNAMICS; INTERSTITIAL FLUID PRESSURES; INTERSTITIAL FLUIDS; MATHEMATICAL MODELING; MICROENVIRONMENT NORMALIZATION; MICROENVIRONMENTS; NORMAL TISSUE; NUMERICAL SIMULATION; SOLID TUMOR; TUMOR MICROVASCULATURE; TUMOR PERIPHERY; VASCULARIZATION; VASCULATURE;

BLOOD; COMPUTER SIMULATION; MATHEMATICAL MODELS;

TUMORS;

EID: 79954481466     PISSN: 02534827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10483-011-1428-7     Document Type: Article

References (20)

1. R. K. Jain R. T. Tong L. L. Munn 2007 Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model Cancer Research 67 6 2729 2735 10.1158/0008-5472.CAN-06-4102 (Pubitemid 46548961)
2. D. Fukumura R. K. Jain 2007 Tumor microvasculature and microenvironment: targets for antiangiogenesis and normalization Microvascular Research 74 72 84 10.1016/j.mvr.2007.05.003 (Pubitemid 350051025)
3. P. E. Huber M. Bischof J. Jenne S. Heiland P. Peschke R. Saffrich H. J. Gröne J. Debus K. E. Lipson A. Abdollahi 2005 Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy Cancer Research 65 9 3643 3655 10.1158/0008-5472.CAN-04-1668 (Pubitemid 40616341)
4. R. T. Tong Y. Boucher S. V. Kozin F. Winkler D. J. Hicklin R. K. Jain 2004 Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors Cancer Research 64 11 3731 3736 10.1158/0008-5472.CAN-04- 0074 (Pubitemid 38697278)
5. C. G. Willett Y. Boucher E. di Tomaso D. G. Duda L. L. Munn R. T. Tong D. C. Chung D. V. Sahani S. P. Kalva S. V. Kozin M. Mino K. S. Cohen D. T. Scadden A. C. Hartford A. J. Fischman J. W. Clark D. P. Ryan A. X. Zhu L. S. Blaszkowsky H. X. Chen P. C. Shellito G. Y. Lauwers R. K. Jain 2004 Direct evidence that the anti-VEGF antibody Bevacizumab has anti-vascular effects in human rectal cancer Nat. Med. 10 145 147 10.1038/nm988 (Pubitemid 38524883)
6. C. G. Willett Y. Boucher D. G. Duda E. di Tomaso L. L. Munn R. T. Tong S. V. Kozin L. Petit R. K. Jain D. C. Chung D. V. Sahani S. P. Kalva K. S. Cohen D. T. Scadden A. J. Fischman J. W. Clark D. P. Ryan A. X. Zhu L. S. Blaszkowsky P. C. Shellito M. Mino-Kenudson G. Y. Lauwers 2005 Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for Bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients J. Clin. Oncol. 23 8136 8139 10.1200/JCO.2005.02.5635 (Pubitemid 46657433)
7. M. S. O'Reilly L. Holmgren Y. Shing C. Chen R. A. Rosenthal M. Moses W. S. Lane Y. Cao E. H. Sage J. Folkman 1994 Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 315 328 10.1016/0092-8674(94)90200-3 (Pubitemid 24324921)
8. M. S. O'Reilly T. Boehm Y. Shing N. Fukai G. Vasios W. S. Lane E. Flynn J. R. Birkhead B. R. Olsen J. Folkman 1997 Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 277 285 10.1016/S0092-8674(00)81848-6 (Pubitemid 28015876)
9. D. Tee J. Distefano III 2004 Simulation of tumor-induced angiogenesis and its response to antiangiogenic drug treatment: mode of drug delivery and clearance rate dependencies J. Cancer Res. Clin. Oncol. 130 15 24 10.1007/s00432-003-0491-1 (Pubitemid 38161243)
10. G. P. Zhao H. Gao J. Wu S. X. Xu M. W. Collins Q. Long C. S. König A. R. Padhani 2006 2D numerical simulation of effect anti-angiogenic factors angiostatin and endostatin on tumor-induced angiogenesis (in Chinese) J. Med. Biomech. 21 4 272 279
11. A. R. A. Anderson M. A. J. Chaplain 1998 Continuous and discrete mathematical models of tumor-induced angiogenesis Bull. Math. Biol. 60 857 900 10.1006/bulm.1998.0042 0923.92011 (Pubitemid 28427465)
12. J. Wu S. X. Xu Q. Long M. W. Collins C. S. König G. Zhao Y. Jiang A. R. Padhani 2008 Coupled modeling of blood perfusion in intravascular, interstitial spaces in tumor microvasculature J. Biomech. 41 996 1004 10.1016/j.jbiomech.2007.12.008
13. J. Wu Q. Long S. X. Xu A. R. Padhani 2009 Study of tumor blood perfusion and its variation due to vascular normalization by anti-angiogenic therapy based on 3D angiogenic microvasculature J. Biomech. 42 712 721 10.1016/j.jbiomech. 2009.01.009
14. L. T. Baxter R. K. Jain 1990 Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics Microvascular Research 40 246 263 10.1016/0026-2862(90)90023-K (Pubitemid 20327678)
15. R. Wan 1993 Dynamics of lymphatic return (in Chinese) Biology Teaching 9 32
16. P. A. Netti S. Roberge Y. Boucher L. T. Baxter R. K. Jain 1996 Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity Microvascular Research 52 27 46 10.1006/mvre.1996.0041 (Pubitemid 26245691)
17. A. R. Pries T. W. Secomb T. Gessner M. B. Sperandio J. F. Gross P. Gaehtgens 1994 Resistance to blood flow in microvessels in vivo Circulation Research 75 904 915 (Pubitemid 24323525)
18. A. R. Pries T. W. Secomb 2005 Microvascular blood viscosity in vivo and the endothelial surface layer Am. J. Physiol. Heart Circ. Physiol. 289 H2657 H2664 10.1152/ajpheart.00297.2005 (Pubitemid 41698582)
19. K. Eriksson P. Magnusson J. Dixelius L. Claesson-Welsh M. J. Cross 2003 Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways FEBS Letters 536 19 24 10.1016/S0014-5793(03)00003-6 (Pubitemid 36206399)
20. R. S. Herbst N. A. Mullani D. W. Davis K. R. Hess D. J. McConkey C. Charnsangavej M. S. O'Reilly H. W. Kim C. Baker J. Roach L. M. Ellis A. Rashid J. Pluda C. Bucana T. L. Madden H. T. Tran J. L. Abbruzzese 2002 Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin J. Clin. Oncol. 20 3804 3814 10.1200/JCO.2002.05.102